CorMedix CRMD Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 91.9%-1.0pp | 92.9%-1.5pp | 94.4%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.8×+0.2× | 0.7×+0.1× | 0.5×— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 3×+0.9× | 2.1×+0.2× | 1.9×-5.9× | 7.8×+3.6× | 4.2×+0.8× | |
| Per Share | ||||||
| Book value per share | $4.70-6.9% | $5.05+16.3% | $4.34+41.5% | $3.07+84.2% | $1.67+15.8% | |
| Valuation | ||||||
| Market capitalization | $605.65M-34.4% | $916.32M+5.5% | $868.17M-18.6% | $1.07B+166% | $401.52M-18.3% | |
| Price / sales | 1.5×-9.6× | 2.9×-1.1× | 4.1×— | —— | —— | |
| Price / book | 1.4×-6.6× | 2.3×-0.1× | 2.3×-2.5× | 4.8×+1.3× | 3.5×-2.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are CorMedix's profit margins?
- CorMedix (CRMD) runs a 91.9% gross margin and a 48.4% operating margin, with a 45.2% net margin.
- Where do CorMedix's ratios come from?
- Every ratio is computed from CorMedix's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
